Edition:
United Kingdom

Vermillion Inc (VRML.OQ)

VRML.OQ on NASDAQ Stock Exchange Capital Market

0.71USD
9:00pm BST
Change (% chg)

$0.03 (+4.62%)
Prev Close
$0.68
Open
$0.69
Day's High
$0.76
Day's Low
$0.69
Volume
10,771
Avg. Vol
36,401
52-wk High
$2.09
52-wk Low
$0.49

Chart for

About

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's... (more)

Overall

Beta: 2.31
Market Cap(Mil.): $92.11
Shares Outstanding(Mil.): 56.16
Dividend: --
Yield (%): --

Financials

  VRML.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.21 -- --
ROI: -130.35 1.79 14.61
ROE: -161.84 3.28 16.33

BRIEF-Vermillion Announces Pricing Of $15 Mln Concurrent Public Offerings Of Stock

* VERMILLION, INC. ANNOUNCES PRICING OF $15 MILLION CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND PREFERRED STOCK

13 Apr 2018

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $72.20 +0.76
Becton Dickinson and Co (BDX.N) $262.01 -0.39
Arrayit Corp (ARYC.PK) $0.06 0.00

Earnings vs. Estimates